These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6616404)

  • 21. Chemotherapy of disseminated malignant melanoma with imidazol carboxamide (DTIC) and cyclophosphamide. Preliminary results.
    Rudolf Z; Plesnicar S
    Anticancer Res; 1982; 2(1-2):37-9. PubMed ID: 7051959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of therapy on the antioxidant status in patients with melanoma.
    Gadjeva V; Dimov A; Georgieva N
    J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MGMT expression levels predict disease stabilisation, progression-free and overall survival in patients with advanced melanomas treated with DTIC.
    Busch C; Geisler J; Lillehaug JR; Lønning PE
    Eur J Cancer; 2010 Jul; 46(11):2127-33. PubMed ID: 20541396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DTIC vs. IFN-alpha plus DTIC in the treatment of patients with metastatic malignant melanoma.
    Rudolf Z; Strojan P
    Neoplasma; 1996; 43(2):93-7. PubMed ID: 8843969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activation of dacarbazine (DTIC) for a human tumor cloning system.
    Metelmann HR; Von Hoff DD
    Int J Cell Cloning; 1983 Apr; 1(1):24-32. PubMed ID: 6674387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chemotherapy of malignant melanoma--current status].
    Karg C; Garbe C; Orfanos CE
    Hautarzt; 1990 Feb; 41(2):56-65. PubMed ID: 2180855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results with methyl-CCNU and DTIC in metastatic melanoma.
    Costanza ME; Nathanson L; Schoenfeld D; Wolter J; Colsky J; Regelson W; Cunningham T; Sedransk N
    Cancer; 1977 Sep; 40(3):1010-5. PubMed ID: 332319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicity and complications of vascular isolation and hyperthermic perfusion with imidazole carboxamide (DTIC) in melanoma.
    Didolkar MS; Fitzpatrick JL; Jackson AJ; Johnston GS
    Cancer; 1986 May; 57(10):1961-6. PubMed ID: 3955502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protocatechuic aldehyde acts synergistically with dacarbazine to augment DNA double-strand breaks and promote apoptosis in cutaneous melanoma cells.
    Pei J; Su Z; Zeng X; Zhong Y; Zhang Y; Yang Y; Lu Q; Li J; Deng Y
    BMC Complement Med Ther; 2023 Apr; 23(1):111. PubMed ID: 37024907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study.
    Avril MF; Aamdal S; Grob JJ; Hauschild A; Mohr P; Bonerandi JJ; Weichenthal M; Neuber K; Bieber T; Gilde K; Guillem Porta V; Fra J; Bonneterre J; Saïag P; Kamanabrou D; Pehamberger H; Sufliarsky J; Gonzalez Larriba JL; Scherrer A; Menu Y
    J Clin Oncol; 2004 Mar; 22(6):1118-25. PubMed ID: 15020614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dacarbazine (DTIC) in malignant melanoma: reduced toxicity with protection from light.
    Koriech OM; Shükla VS
    Clin Radiol; 1981 Jan; 32(1):53-5. PubMed ID: 7214822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dimethyl triazeno imidazole carboxamide and combination therapy for melanoma. IV. Late results after complete response to chemotherapy (Central Oncology Group protocols 7130, 7131, and 7131A).
    Hill GJ; Krementz ET; Hill HZ
    Cancer; 1984 Mar; 53(6):1299-305. PubMed ID: 6362841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental dacarbazine antitumor activity and skin toxicity in relation to light exposure and pharmacologic antidotes.
    Dorr RT; Alberts DS; Einspahr J; Mason-Liddil N; Soble M
    Cancer Treat Rep; 1987 Mar; 71(3):267-72. PubMed ID: 3815394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma.
    Thatcher D; Lind M; Morgenstern G; Carr T; Chadwick G; Jones R; Craig P
    Cancer; 1989 Apr; 63(7):1296-302. PubMed ID: 2646005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical thermochemotherapy. A controlled trial in advanced cancer patients.
    Storm FK; Silberman AW; Ramming KR; Kaiser LR; Harrison WH; Elliott RS; Haskell CM; Sarna G; Morton DL
    Cancer; 1984 Feb; 53(4):863-8. PubMed ID: 6362831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DTIC therapy in patients with malignant intra-abdominal neuroendocrine tumors.
    Altimari AF; Badrinath K; Reisel HJ; Prinz RA
    Surgery; 1987 Dec; 102(6):1009-17. PubMed ID: 2825370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperthermic antiblastic perfusion with DTIC in stage IIIA-IIIAB melanoma of the extremities.
    Vaglini M; Belli F; Marolda R; Prada A; Santinami M; Cascinelli N
    Eur J Surg Oncol; 1987 Apr; 13(2):127-9. PubMed ID: 3556593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrinoma with multiple liver metastases: effectiveness of dacarbazine (DTIC) therapy.
    Ohshio G; Hosotani R; Imamura M; Sakahara H; Ochi J; Kubota N
    J Hepatobiliary Pancreat Surg; 1998; 5(3):339-43. PubMed ID: 9880785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective toxicity of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide toward hypoxic mammalian cells.
    Rauth AM; Mohindra JK
    Cancer Res; 1981 Dec; 41(12 Pt 1):4900-5. PubMed ID: 7198008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New modifications in isolated extremity perfusion ].
    Aigner K; Hild P; Hundeiker M
    Z Hautkr; 1982 Jul; 57(14):1044-54. PubMed ID: 6889794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.